DMU2139
Product Specifications
UNSPSC Description
DMU2139 is a potent and specific CYP1B1 inhibitor, with IC50s of 9 nM and 795 nM for CYP1B1 and CYP1A1, respectively.
Target Antigen
Cytochrome P450
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/DMU2139.html
Purity
98.0
Solubility
DMSO : 77.5 mg/mL (ultrasonic)|Ethanol : 5 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2C=C(OC)C=CC2=C1)/C=C/C3=CC=CN=C3
Molecular Weight
289.33
References & Citations
[1]Horley NJ, et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines. Eur J Med Chem. 2017 Mar 31;129:159-174.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101285/DMU2139-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101285/DMU2139-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1821143-80-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS3900297-01 0.5 mg
Goat anti-Rat IgG Heavy and Light Chain Cross-Adsorbed Antibody Cy3 Conjugated
Ask
View Details MBS3900297-02 5x 0.5 mg
Goat anti-Rat IgG Heavy and Light Chain Cross-Adsorbed Antibody Cy3 Conjugated
Ask
View Details 
